Abstracts (HTML) List of Authors

Dalekos, G

Autoimmune hepatitis with normal IgG at diagnosis: Subtype without selective elevation of IgG but similar histological features and treatment response

Dalton, H

Anti-HEV seroprevalence rate in the Americas

Damm, G

Azazytidin and Vitamin C modulates the expression profile of epigenetic modulators in HepG2 and increase their metabolic function

Dammermann, W

Chronic pancreatitis in patients with liver cirrhosis negatively affects graft survival after liver transplantation

Dandri, M

Interferon α treatment leads to reappearance of the Smc5/6 complex in HBV-infected humanized mice and to its renewed degradation upon viral rebound
Efficacy of HDV mono-infection with genotype 1 and 3 in CRPISPR/Cas generated humanized NTCP mice compared to human liver chimeric mice
Mutations in the basal core promoter of HBV lead to intracellular accumulation of viral nucleic acids in vivo
Hepatitis B virus activates expression of the RIG-like receptor pathway in murine intrahepatic cells in humanized mice
T cells transiently expressing TCRs against HBV show antiviral activity in HBV/HDV co-infected humanized mice
Hepatitis B virus-specific T cell receptors with high functional redirect T cells to eliminate HBV

Darstein, F

Donor but not recipient CRS predicts fibrosis progression after liver transplantation in a large cohort of HCV-positive and negative patients

Datz, C

Heterozygous carriage of the alpha1-antitrypsin PiZ variant increases the risk to develop liver fibrosis

Dayoub, R

Augmenter of Liver Regeneration (ALR) regulates the proinflammatory marker intracellular adhesion molecule-1 (ICAM-1, CD54) in liver cells

de Bruin, A

Deletion of MyD88 in non-parenchymal cells, but not in parenchymal cells attenuates the progression of hepatocellular carcinoma

Del Pino, S

Sicherheit und Praktikabilität der laparoskopischen Leberresektion (LLR) des Hepatozellulären Karzinoms (HCC) bei Leberzirrhose

Deltenre, P

Heterozygous carriage of the alpha1-antitrypsin PiZ variant increases the risk to develop liver fibrosis

Demir, M

Could inherited predisposition drive fatty liver disease in non-obese Germans? Results from eight tertiary referral centers

Denzer, U

Blood-borne HEV transmission: A one year experience with routine HEV screening at a tertiary center
Transfusion-transmitted hepatitis E virus infections: a risk for immunosuppressed patients
Does long-term remission by endoscopic treatment modalities benefit patient and graft survival in biliary strictures after liver transplantation?

Deutschmann, K

Role of the bile acid receptor TGR5 (GPBAR1) in cholangiocarcinoma (CCA)

Dieckhoff, J

T cell mediated cholangitis alters bile acid metabolism

Diedrich, T

Phenotypische Analyse der Immunzellsignatur in NAFLD

Diehl, L

CEACAM1 controls immune-mediated liver injury by promoting IL-2-dependent Treg induction

Dietel, M

Evolutionary distance predicts recurrence after liver transplantation in multifocal hepatocellular carcinoma

Dietrich, P

A novel Krueppel-like factor 12/Interleukin-6 signal transducer – microRNA-188-5 p interaction reveals therapeutic targets for hepatocellular carcinoma
Sorafenib-resistance is mediated by a novel Kirsten rat sarcoma-microRNA-axis in hepatocellular carcinoma
Novel feedback inhibition of the let-7 microRNA regulator and stem cell marker Lin 28 homolog A by tumorsuppressor miR-622 in hepatocellular carcinoma
The long non-coding RNAs lncRNA-ADM-2 and lncRNA-NBPF3-9 outline potential novel targets for hepatocellular carcinoma
Expression of different histone deacetylases and functional effects of histone deacetylase inhibitors in hepatocellular carcinoma
Muscle RAS oncogene homolog is a novel therapeutic target gene contributing to hepatocellular carcinoma progression and sorafenib-resistance
TNF receptor superfamily member 10 d is a novel diagnostic and therapeutic target in hepatocellular carcinoma progression and sorafenib-resistance
Combined effects of polo-like kinase 1 and harvey rat sarcoma in hepatocellular carcinoma reveal novel therapeutic strategies
The role of mechanistic target of rapamycin complex 2-component RICTOR in hepatocellular carcinoma progression and sorafenib-resistance

Diken, M

In vivo gene silencing in the liver: Comparison of siRNA-loaded non biodegradable vs. biodegradable nanohydrogel particles for antifibrotic therapy

Ditschkowski, M

HBV reactivation in allogeneic stem cell transplant recipients: risk factors, outcome and role of HBV mutations

Dittmer, M

Dynamic communication patterns determine the endothelial cell rheostat in liver capillarization and tumorigenesis

Dold, L

CD4 regulatory T cells in hepatocellular carcinoma with different etiologies

Dombrowski, F

Hepatocellular clear cell foci after combined intraportal pancreatic islet transplantation and knockout of chREBP in diabetic mice
The CDK4/6 inhibitor Palbociclib and the mTOR inhibitor MLN0128 are effective for the treatment of experimental intrahepatic cholangiocarcinoma
The pan-mTOR inhibitor MLN0128 is effective against intrahepatic cholangiocarcinoma in mice

Donner, L

Platelet defects upon surgical liver disease models in mice

Dooley, S

SOX9 is a crucial transcription factor determining intrahepatic cholangiocarcinoma resistance to chemotherapy
Alcohol triggers IL-6 mediated inflammatory response in a new mouse model of acute-on-chronic liver injury
Structural and molecular signatures of disease progression from NASH to HCC in mouse model and human
Identification of metabolic prognostic biomarkers in carbon tetrachloride-induced liver fibrosis using MAS-H1-NMR
Inhibition of TGF-β1 pathway reduces fibrosis in ABCB4-/- mouse model
Alcohol aggravates IL-6 mediated inflammatory response and hepatic steatosis in a new mouse model of acute-on-chronic liver injury
Deciphering the Role of Transforming Growth Factor Beta (TGF-β1&2) during Tumor Promotion and Suppression in Primary Liver Cancer
Increase HCC proliferation with TGF-βR1 inhibition and TLR7 stimulation; are they two faces for one coin?

Dörfler, A

Functional connectivity reveals altered activation of distinct brain areas in pruritus of cholestasis

Dörge, P

Treatment strategies for patients with decompensated liver cirrhosis due to HCV infection – Antiviral treatment or liver transplantation first?

Döring, C

Differential modulation of hepatitis C virus replication and innate immune pathways by synthetic calcitriol analogs

Drenth, J

Autoimmune hepatitis with normal IgG at diagnosis: Subtype without selective elevation of IgG but similar histological features and treatment response

Drescher, H

L-Selectin (CD62L) drives development and progression of non-alcoholic steatohepatitis (NASH) in mouse and man

Dröge, C

A custom-designed Next Generation Sequencing Panel for analysis of patients with assumed genetically determined cholestatic liver disease

Drolz, A

Phenotypische Analyse der Immunzellsignatur in NAFLD
Persistierender Aszites nach TIPS-Implantation ist prädiktiv für ein geringeres transplantationsfreies Überleben bei Patienten mit Leberzirrhose
Aussagekraft nicht-invasiver Verfahren zur Fibrosequantifizierung bei NAFLD-Patienten mit moderater versus morbider Adopisitas

Drucker, E

Ganglioside GM2 activator (GM2A) is as a novel pro-survival p53 target in hepatocellular carcinoma

Düber, C

Liver vein infiltration in patients with hepatocellular carcinoma in a large German cohort

Duong, S

Heterologous immune vaccination induces specific therapeutic CD8 T-cell immune responses against tumor-associated antigens expressed in HCC

Dürl, S

About the Functional Role of Ductular Reactions in Severe Liver Damage